Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Acute lymphoblastic lymphocytic leukemia ALL )
27,759 results
  • Isolation, purification, characterisation and application of L-ASNase (L-ASNase): A review. [Journal Article]
  • RPRecent Pat Biotechnol 2018 Oct 12
  • Paul T, Mondal A, Bandyopadhyay TK
  • CONCLUSIONS: L-ASNase is used as a potential anti-tumour medicine. It plays a very much essential role for the growth of tumour cells. Tumour cells require a lot of asparagine for their growth. But ASNase converts to aspartate and ammonia from asparagine. So the tumour cell does not proliferate and fails to survive. The L-ASNase is used as the medicine for the major type of cancer like acute lymphocytic leukaemia (ALL), brain. It also used as a medicine for central nervous system (CNS) tumours, and also for neuroblastoma. Two types of L-ASNase have been found.L-ASNase becomes a powerful anti-tumour medicine and researchers should develop a potent strain of asparaginase which can produce asparaginase in the industrial level. It also used in pharmaceutical industry and food industry as a broad scale.
  • Allogeneic CAR-T Cells: More than Ease of Access? [Review]
  • CCells 2018 Oct 01; 7(10)
  • Graham C, Jozwik A, … Benjamin R
  • Patient derived anti-CD19 chimeric antigen receptor-T (CAR-T) cells are a powerful tool in achieving a complete remission in a range of B-cell malignancies, most notably B-acute lymphoblastic leukaem...
New Search Next